Literature DB >> 25921765

Prenatal dexamethasone-induced programmed hypertension and renal programming.

Jiunn-Ming Sheen1, Hong-Ren Yu1, Mao-Meng Tiao1, Chih-Cheng Chen1, Li-Tung Huang2, Hsin-Yu Chang1, You-Lin Tain3.   

Abstract

AIMS: Antenatal glucocorticoids can induce long-term effects on offspring health, including hypertension. Programmed hypertension has been observed in a prenatal dexamethasone (DEX) exposure model. However, how renal programming responds to prenatal DEX at different stages of development and the impact of DEX on programmed hypertension remain unclear. Therefore, we utilized RNA next-generation sequencing (NGS) to analyze the renal transcriptome in the offspring to examine whether key genes and pathways are responsible for DEX-induced renal programming and hypertension. MAIN
METHODS: Pregnant rats received intraperitoneal dexamethasone from gestational day 16 to 22. Prenatal DEX-induced programmed hypertension was examined in male offspring at 16 weeks of age. KEY
FINDINGS: Prenatal DEX modified 431 renal transcripts from the nephrogenesis stage to adulthood in a constant manner. At the pre-hypertensive and established hypertension stages, we identified 11 and 13 differentially expressed genes related to blood pressure regulation, respectively. Among these genes, Npr3, Ptgs2, Agt, Edn3, Ephx2, Agtr1b, and Gucy1a3 are associated with endothelium-derived hyperpolarizing and contractile factors (EDHF and EDCF). Genes in the arachidonic acid metabolism pathway may potentially be key genes contributing to programmed hypertension. In addition, DEX induced soluble epoxide hydrolase expression (Ephx2 gene encoding protein). SIGNIFICANCE: Prenatal DEX elicits an imbalance between EDHFs and EDCFs that might lead to renal programming and hypertension. The arachidonic acid metabolism pathway is a common pathway contributing to programmed hypertension. Our results highlight candidate genes and pathways involved in renal programming as targets for therapeutic approaches to prevent programmed hypertension in children exposed to antenatal corticosteroids.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; Endothelium-derived contractile factor; Endothelium-derived hyperpolarizing factor; Glucocorticoid; Hypertension; Next-generation sequencing

Mesh:

Substances:

Year:  2015        PMID: 25921765     DOI: 10.1016/j.lfs.2015.04.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

Review 1.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 2.  Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney.

Authors:  You-Lin Tain; Jaap A Joles
Journal:  Int J Mol Sci       Date:  2015-12-25       Impact factor: 5.923

Review 3.  Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis.

Authors:  Frank Verhoeven; Clément Prati; Katy Maguin-Gaté; Daniel Wendling; Céline Demougeot
Journal:  Arthritis Res Ther       Date:  2016-11-05       Impact factor: 5.156

Review 4.  Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

Review 5.  Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2017-04-15       Impact factor: 5.923

Review 6.  Developmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2017-02-11       Impact factor: 5.923

Review 7.  Developmental Programming of Renal Function and Re-Programming Approaches.

Authors:  Eva Nüsken; Jörg Dötsch; Lutz T Weber; Kai-Dietrich Nüsken
Journal:  Front Pediatr       Date:  2018-02-27       Impact factor: 3.418

8.  Maternal Resveratrol Therapy Protects Male Rat Offspring against Programmed Hypertension Induced by TCDD and Dexamethasone Exposures: Is It Relevant to Aryl Hydrocarbon Receptor?

Authors:  Chien-Ning Hsu; Yu-Ju Lin; Pei-Chen Lu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

9.  Early Postweaning Treatment with Dimethyl Fumarate Prevents Prenatal Dexamethasone- and Postnatal High-Fat Diet-Induced Programmed Hypertension in Male Rat Offspring.

Authors:  Yu-Ju Lin; I-Chun Lin; Hong-Ren Yu; Jiunn-Ming Sheen; Li-Tung Huang; You-Lin Tain
Journal:  Oxid Med Cell Longev       Date:  2018-02-15       Impact factor: 6.543

10.  Prenatal dexamethasone and postnatal high-fat diet have a synergistic effect of elevating blood pressure through a distinct programming mechanism of systemic and adipose renin-angiotensin systems.

Authors:  Hong-Ren Yu; You-Lin Tain; Mao-Meng Tiao; Chih-Cheng Chen; Jiunn-Ming Sheen; I-Chun Lin; Shih-Wen Li; Ching-Chou Tsai; Yu-Ju Lin; Kai-Sheng Hsieh; Li-Tung Huang
Journal:  Lipids Health Dis       Date:  2018-03-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.